396 related articles for article (PubMed ID: 18653982)
41. Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran.
Ghavanini AA; Sabri MR
East Mediterr Health J; 2000; 6(5-6):1114-6. PubMed ID: 12197336
[TBL] [Abstract][Full Text] [Related]
42. Changing trends in seroprevalence rates of transfusion-transmitted diseases among blood donors in Jordan.
Souan L; Siag M; Al-Salahat H; Al-Atrash T; Sughayer MA
BMC Infect Dis; 2021 May; 21(1):508. PubMed ID: 34059011
[TBL] [Abstract][Full Text] [Related]
43. Prevalence of hepatitis B and C viruses in pre-dialysis patients with chronic renal failure.
Salako BL; Ayodele OE; Kadiri S; Arije A
Afr J Med Med Sci; 2002 Dec; 31(4):311-4. PubMed ID: 15027769
[TBL] [Abstract][Full Text] [Related]
44. Seroprevalence of markers of viral hepatitis in Yemeni healthcare workers.
Shidrawi R; Ali Al-Huraibi M; Ahmad Al-Haimi M; Dayton R; Murray-Lyon IM
J Med Virol; 2004 Aug; 73(4):562-5. PubMed ID: 15221900
[TBL] [Abstract][Full Text] [Related]
45. Hepatitis C virus : prevalence in Lebanese blood donors and brief overview of the disease.
Araj GF; Kfoury-Baz EE; Barada KA; Nassif RE; Alami SY
J Med Liban; 1995; 43(1):11-6. PubMed ID: 8676356
[TBL] [Abstract][Full Text] [Related]
46. Seroprevalence and subtype distribution of hepatitis C virus among blood donors and intravenous drug users in northern/northeastern Thailand.
Apichartpiyakul C; Apichartpiyakul N; Urwijitaroon Y; Gray J; Natpratan C; Katayama Y; Fujii M; Hotta H
Jpn J Infect Dis; 1999 Jun; 52(3):121-3. PubMed ID: 10507992
[TBL] [Abstract][Full Text] [Related]
47. [Epidemiological information obtained from anti-hepatitis C virus screening in blood donors and candidates for autologous transfusion from 1992 to 1996 in the Alpes-Maritimes region].
Ouzan D; Pesle B; Baldini E; Rimbourg H; Darphin F; Cohen N; Brichetti A; Follana R
Gastroenterol Clin Biol; 2000 Mar; 24(3):337-41. PubMed ID: 10804343
[TBL] [Abstract][Full Text] [Related]
48. Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria.
Fasola FA; Kotila TR; Akinyemi JO
Intervirology; 2008; 51(6):427-31. PubMed ID: 19321928
[TBL] [Abstract][Full Text] [Related]
49. [Prevalence of VHB and VHC serological markers among blood donors in the capital state of Veracruz, Mexico].
Valerio-Ureña J; Vásquez-Fernández F; Pérez-Sosa JA; Cortazar-Benitez LF; Chávez-Tapia NC; Ruvalcaba-Rojas OA; Torres-Medina V; Ocejo-Rodríguez A
Gac Med Mex; 2009; 145(3):183-7. PubMed ID: 19685823
[TBL] [Abstract][Full Text] [Related]
50. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
[TBL] [Abstract][Full Text] [Related]
51. [Epidemiological assessment of the hepatitis B and C infectious disease markers in Baku and Nakhtchivan healthy population].
Georgian Med News; 2010; (184-185):40-4. PubMed ID: 20834074
[TBL] [Abstract][Full Text] [Related]
52. Hepatitis B and C seroprevalence in the Lebanese population.
Baddoura R; Haddad C; Germanos M
East Mediterr Health J; 2002 Jan; 8(1):150-6. PubMed ID: 15330570
[TBL] [Abstract][Full Text] [Related]
53. [Anti-HB-core antibodies as a surrogate marker in blood donors].
Blejer JL; Saguier MC; Salamone HJ
Sangre (Barc); 1999 Jun; 44(3):240-1. PubMed ID: 10481590
[No Abstract] [Full Text] [Related]
54. The risk of transfusion-acquired hepatitis-C virus infection among blood donors in Port Harcourt: the question of blood safety in Nigeria.
Erhabor O; Ejele OA; Nwauche CA
Niger J Clin Pract; 2006 Jun; 9(1):18-21. PubMed ID: 16986284
[TBL] [Abstract][Full Text] [Related]
55. [Prevalence of serum markers of hepatitis B and C virus in blood donors of Nouakchott, Mauritania].
Lo BB; Meymouna M; Boulahi MA; Tew M; Sow A; Ba A; Sow MB
Bull Soc Pathol Exot; 1999 May; 92(2):83-4. PubMed ID: 10399594
[TBL] [Abstract][Full Text] [Related]
56. Risk factors and seroprevalence of hepatitis C antibody in blood donors in Nigeria.
Halim NK; Ajayi OI
East Afr Med J; 2000 Aug; 77(8):410-2. PubMed ID: 12862062
[TBL] [Abstract][Full Text] [Related]
57. Hepatitis C virus infection in asymptomatic male volunteer blood donors in Karachi, Pakistan.
Akhtar S; Younus M; Adil S; Jafri SH; Hassan F
J Viral Hepat; 2004 Nov; 11(6):527-35. PubMed ID: 15500553
[TBL] [Abstract][Full Text] [Related]
58. [Seroprevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among blood donors in Segou, Mali].
Koné MC; Sidibé ET; Mallé KK; Beye SA; Lurton G; Dao S; Diarra MT; Dao S
Med Sante Trop; 2012; 22(1):97-8. PubMed ID: 22868738
[TBL] [Abstract][Full Text] [Related]
59. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
Singh B; Verma M; Verma K
Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
[TBL] [Abstract][Full Text] [Related]
60. Seroprevalence of human immunodeficiency virus, hepatitis B virus and hepatitis C virus among eye donors.
Mahalakshmi B; Madhavan HN; Pushpalatha R; Margarita S
Indian J Ophthalmol; 2004 Mar; 52(1):61-2. PubMed ID: 15132383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
